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Introduction
Toll-like receptors (TLRs) a portion of the family of
Pattern Recognition Receptors (PRR) have gained great
interest in scientific community. This group of highly
conserved receptors, initially restricted to cells of the
immune system, was shown to activate innate and adap-
tive immune responses. Later TLRs were demonstrated
on cells of various epithelia. Their ability to act as sen-
sors of various pathogens, to discriminate between self
and non-self provided new tools and weapons in the
struggle for good health and survival  of human beings.
TLRs exist in several families differing in the ability of
recognition of particular ligand such as sugars, complex
lipids, nucleic acids and other, collectively called
Pathogen Recognition Molecular Patterns (PAMPs). All
of them are natural ligands of TLRs able to activate
intrinsic cell machinery following TLR-ligand binding.
This in turn results in activation of transcription factors
such as NF-κB and their penetration to cell nucleus.
This leads to transcription of several genes encoding,
among others proinflammatory cytokines [1,2]. During
last 10-20 years it became obvious that TLRs play piv-
otal role in various pathological conditions, especially
local and systemic infections, because they trigger both
innate and adaptive immunity of the affected host [3].
Apart from natural ligands derived mainly  from various
pathogens there is an evidence that various substances
from our body may act as TLR ligands, often being
result of metabolism or pathologic process such as uric
acid, heat shock proteins, apoptotic fragments and oth-
ers. They are known as Danger Associated Molecular
Patterns (DAMPs) [4]. The third type of TLR ligands
are synthetic agonists of TLRs, produced more and
more often by pharmaceutical companies.
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Apart from normal epithelia, TLRs have been
shown to be expressed on cells of several cancers,
including skin [5],  breast [6], lung [7], colon [8], liver
[9], ovary [10] and other tumors [11]. Cells of particu-
lar cancers express various TLRs and their wealth sug-
gests that they may fulfill some function related to
tumor growth and progression. In fact,  it was demon-
strated by several investigators,  that TLRs may act in
favor of tumor, providing positive stimuli for its pro-
gression. On the other hand, appropriate TLR ligands
may suppress tumor growth, as it was noticed in some
tumors. For example imiquimod, man-made ligand for
TLR7, was shown to inhibit growth of skin carcinoma
when applied as an ointment [12,13]. The positive
effect of imiquimod was found to be immunologically
mediated, because it was due up-regulation of effector
function of T cells [14]. 
We have shown that the cells of laryngeal carcino-
ma express at least three TLRs, namely TLR2, TLR3
and TLR4 [15]. It was detected by means of immuno-
histochemistry on frozen tissue sections of surgical
specimens of this tumor. In order to get more informa-
tion about the expression and function of TLRs in this
cancer we decided to search for other TLRs on estab-
lished cell lines of this tumor and to culture them in the
presence of appropriate TLR ligands. It will be shown
that there is a wide distribution of TLRs in the cancer
in question and that their expression seems to be func-
tional, as evidenced by the movement of TLR protein
from cell interior to cell surface, following contact
with respective ligand.  
Materials and methods
Cell line and culture conditions. Cell lines used included four
ones obtained from Pittsburgh Cancer Institute (PCI), USA, cour-
tesy of prof. Theresa Whiteside, one (HeP2) from  ATCC collection
(ATCCCCL23) and one (UT-35) obtained owing to courtesy of
Prof. K. Szyfter (Institute of Human Genetics, Polish Academy of
Sciences, Poznan, Poland). Their basic characteristics are shown in
Table 1. All cell lines were cultured in RPMI 1640 medium sup-
plemented with 10% fetal calf serum (FCS),  2mM L-glutamine
and antibiotics, penicillin + streptomycin in final concentration of
each 100 μg/ml in standard culture conditions 37°C, 5% CO2 and
95% humidity.
Immunocytochemistry. Cells were released from the bottom cul-
ture flask by treatment with 1% trypsin. In order to restore cell sur-
face molecules digested by the enzyme, cells were suspended for
24 hrs in 10% FCS. Cell sediments (cytospins) were prepared
thereafter by means of cytocentrifuge (Shandon) at 1000 rpm/min
for 4 min. Cytospins were dried, fixed in chilled acetone for 
10 min, dried again and subjected overnight at 40°C in humid
chamber to the reaction with respective polyclonal (goat) antibod-
ies anti-TLR2 up to TLR10. Their basic characteristics and source
are shown in Table 2. The cells were then extensively washed in
TBS (physiological saline buffered with TRIS buffer pH 7,6),
incubated with anti-goat secondary antibody and thereafter sub-
jected to ABC (Avidin Biotin peroxidase anti peroxidase Complex)
reaction, using commercial ABC kit (Santa Cruz Biotechnology).
Reaction product was visualized by means of DAB (diaminoben-
zidine). Cells were washed later as above and counterstained with
Mayer's hematoxylin, washed in tap water and embedded in glyc-
erogel. Control reactions included replacement of primary anti-
body by TBS and preincubation of primary antibody with respec-
tive blocking peptide (Santa Cruz)  used previously for the pro-
duction of given TLR antibody. In addition, red blood cells and
cultured human fibroblasts were tested using TLR antibodies. All
control reactions gave uniformly negative results.
The cytospins following immunohistochemical reaction were
assessed at high power light microscope by semiquantitative way
by two independent observers. Four compartments of reaction pos-
itivity were delineated:
+++ 75-100% positive cells
++ 25-75% positive cells
+  >25% positive cells
- lack positive cells
Apart from the percent of positive cells the attention was also
paid to localization of the reaction product. The latter could be dis-
cerned as cell surface bound and cytoplasmic one.
Cancer cell line co-culture with TLR ligands. Six cancer cell
lines (Table 1) in a quantity 5×105 cells per well, were cultured for
24 hrs in the presence of TLR ligands. The list of ligands used is
shown in Table 3. Quantities of particular ligand added to the cul-
ture was in accordance  with recommendations of the manufactur-
er (InVivoGen). Control cells were cultured in a parallel without
added ligand. 
After termination of culture cells were resuspended in PBS and
subjected to respective anti-TLR fluorochrome labeled monoclon-
al antibody (Moab) reaction, with the specificity corresponding to
used ligand. TLR1, 2, 3 and 4 Moabs were purchased in Santa Cruz
Biotechnology, while TLR5, 6, 7, 8, 9 and 10 ones originated from
IMGENEX. The direct immunofluorescence was carried out with
the exception of anti TLR7, in which following unlabelled primary
antibody anti mouse IgG1-FITC was applied. In each case control
reaction was carried out using labelled  mouse IgG1FITC/IgG2aPE
in order to exclude non-specific fluorescence of used antibodies
(isotypic control). Cells were incubated with appropriate reagent
for 15 min in the dark. After extensive washing 104 cells were sub-
jected to acquisition in flow cytometric analyser Canto (BD) and
analysed by Fax Diva software.
Total RNA isolation and RT-PCR. Total RNA was isolated using
TRIzol Plus RNA Purification Kit (Invitrogen), starting with 6-9 ×
106 cells. Cell lines used for isolation were: PCI 4B, PCI 19, PCI
37A, PCI 37B, SSC UT 35 and Hep 2. Total RNA was isolated
according to the kit manufacturer's recommendations. After isola-
tion the amount of RNA was measured using NanoDrop ND 1000
UV-Vis Spectrophotometer (NanoDrop Technologies) and frozen.
RT-PCR reaction was performed using OneStep RT-PCR Kit
(Qiagen) with 1 μg of total RNA for each reaction tube. The proto-
col of reaction was supplied in manufacturer's handbook. Primers for
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Table 1. Larynx carcinoma cell lines used.
Source: [9]
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GAPDH gene were used as an internal control. 35 cycles with
annealing temperature of 54°C (61°C for TLR7) were performed on
Mastercycler epgradient (Eppendorf) thermocycler. Reaction prod-
ucts were resolved by 1.5% agarose electrophoresis, stained with
ethidium bromide and visualised on UV transilluminator. GeneRuler
100 bp Plus DNA Ladder (Fermentas) was used as a mass marker.
Since RT-PCR reaction for TLR7 was negative on RNA
extracted from all used cell lines, an gradient RT-PCR reaction was
performed. According to the results of gradient RT-PCR reaction,
in repeated experiment a higher temperature of annealing (61°C)
was used in case of TLR7. The sequence of primers used  and
expected product sizes are shown in Table 4.
Results
Immunocytochemistry  (ICC) on cell sediments
All cell lines expressed some TLRs when tested versus
TLR2-10 antibodies. Individual cell lines differed
however in the reactivity  with particular anti-TLR
reagents. Most of cells expressed cytoplasmic staining,
but some have shown membrane-bound reaction,
when tested with given antibody. When TLR antibod-
ies were mixed and incubated with respective blocking
peptide prior the reaction with cells, the staining came
out uniformly negative. Detailed data of cells reactivi-
ty with anti-TLRs are depicted in the Table 5. Exam-
ples of ICC staining are depicted in Fig. 1.
RT-PCR studies
Results of RT-PCR studies are shown in the Fig 2
RT-PCR results showed that mRNAs for almost all
TLRs examined in this study were expressed in  cell
lines studied. The expression level differed depending
on the TLR being examined and cell line used for
RNA isolation. Only one reaction product was not
observed on agarose gel (TLR3 in PCI 37A). Bands of
few RT-PCR products were much weaker comparing
to others. They included TLR2 in SSC-UT-35, TLR7
in PCI 4B, TLR9 in PCI 4B, PCI 19, Hep-2 TLR10 in
Hep-2. On the other hand, mRNAs for TLR1, TLR4,
TLR6 had uniformly strong expression. 
RT-PCR for TLR7 performed in higher temperature
(61°C) of annealing (see: Materials and methods) result-
ed in visible reaction products. The same reaction for
TLR7 performed in annealing temperature of other
TLRs (54°C) gave no visible products (see Fig. 2). We
decided to perform gradient RT-PCR reaction,  thereafter
the annealing temperature for TLR7 RT-PCR was set at
61°C for further experiments.
Table 2. Anti-TLR primary antibodies used.
Table 3. TLR ligands used.
627TLRs in larynx cancer
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(4): 627 (624-631) 
Doi: 10.2478/v10042-010-0077-0
Cell culture studies
Cells of each cell line tested were cultured for 24 hrs
with or without respective TLR1-10 ligands. Following
culture cells were washed and subjected to the reaction
with TLR Moabs and evaluated by flow cytometry for
MFI (Mean Fluorescence Intensity) expression.
In general, cytoplasmic expression dominated over
that  without prior incubation with ligand. Culture of
cells with ligand resulted usually in the decrease of
cytoplasmic MFI. In contrast, MFI surface expression
of some TLRs was higher after ligand exposure.
TLR1, TLR6 and TLR10 were cultured in medium
only, because their ligands were not available. The
reactivity of all cell lines with and without contact with
ligands is shown in Fig. 3  (A-F). It is visible that MFI
of individual TLRs varied on particular cell lines but
that of some TLRs, namely TLR 7, 9 and partly TLR5
appeared apparently high on most cell lines. Curiously
enough, culture with ligand resulted in the fall of some
cytoplasmic TLR expression on the expense of surface
one. It has been depicted in Fig. 4, where as a example
of it, TLR7 on HeP-2 cells have shown such bizarre
shift of expression.  
Discussion
Tumor established cell lines do not reflect precisely
properties and traits of neoplastic cells growing in
vivo. They are not under influence of several factors
derived from  tumor bearing host, such as tumor infil-
trating inflammatory cells, cytokines, cell adhesion
molecules etc. On the other hand, cell lines provide
several advantages in study of cancer biology such as
sample homogeneity, the ease of culture and its vari-
ous modifications and the least but not the last, avoid-
ance of animal studies [16]. 
Laryngeal carcinoma, major representative of head
and neck cancer group, is the fourth the most common
malignancy of middle-aged and old men in Poland
responsible for high mortality.  In spite of the fact that
more than 90% of these tumors are highly differentiat-
ed squamous cell carcinomas, mortality rates for this
Fig. 1. Examples of immunocyto-
chemistry reactions of larynx carcino-
ma cells with anti-TLR Abs. a. Hep-
2 cells. Normal goat serum instead of
TLR antibody, followed by ABC
staining kit. Control reaction (original
magnification x40). b. PCI 37A cells.
Anti-TLR3 Ab. Surface staining of
cells (original magnification ×100). c.
PCI 37B cells. Anti-TLR4 Ab and as
above. Partial surface staining of cells
(original magnification ×100). d.
PCI37B cells. Anti-TLR9 Ab, and as
above. Cytoplasmic staining of cells
(original magnification ×100). e. Hep-
2 cells. Anti-TLR7 Ab and as above.
Cytoplasmic staining of cells (original
magnification ×100). f. PCI37B cells.
Anti-TLR10 Ab and as above. Cyto-
plasmic staining of cells (original
magnification ×100). Bar – 20 μm.
Table 4. Sequences of primers used in RT-PCR reaction and
expected product sizes.
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disease have not improved significantly in the past 50
years. It is typical environmental cancer in which
major etiological role is played by smoking and asso-
ciated alcoholic beverages. Its immunological and
genetic features have been studied extensively. Sever-
al molecular aberrations in this tumor were described
as well as  the existence of specific cell-mediated
immunity [17,18]  The latter however, has been shown
to have no major impact on tumor growth and pro-
gression. This explains the current trend in tumor
immunology to shift to evolutionally older, evolution-
arily conserved branch of immunology, namely innate
immunity. The latter ensures protection to myriads of
various invertebrate creatures, is active from the very
beginning of life and possess robust means and mech-
anisms for anti-microbial defense. Moreover, from
unknown reasons, invertebrates are practically free
from neoplasia. Fortunately, most of mechanisms of
innate immunity have been preserved in vertebrates
including man. Toll-like receptors are good example of
Table 5. TLRs expression on larynx carcinoma cell lines. Immunocytochemical studies.
ND – not done
Fig. 2. RT-PCR reaction. Total RNA used as a template was isolated from cell
lines: A – PCI 4B, B – PCI 19, C – PCI 37A, D – PCI 37B, E – SSC-UT-35,
F – Hep-2. 1-10 – TLR1-10, G – GAPDH, M – mass marker. RT-PCR reac-
tion for TLR7 was repeated using higher temperature of annealing (61°C).
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such  mechanism. They were initially detected in 
a Drosophila fly and were found to be  involved in its
dorso-ventral embryonic development and anti-fungal
immunity [19]. TLRs are now well established factors
participating in recognition of several bacterial, viral
and fungal pathogens, both in animals and man. Their
role in tumors is far from clear, but the interest is
growing due to several reports in the literature claim-
ing various, both positive and negative impact on
tumor growth. 
We have studied initially the expression of TLRs on
six established cell lines of larynx cancer by means of
Fig. 3. Short-term culture of cancer cell lines with TLR ligands. Surface and cytoplasmic MFI expression of given TLR before and after
culture with respective ligand A – Hep-2 line, B – UT35, C – PCI19, D – PCI37A, E – PCI37B, F – PCI4B.
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immunocytochemistry. Unexpectedly, we found
almost universal expression of TLRs from 2 to 10 on
some but not all cell lines. Cytoplasmic TLR expres-
sion dominated over surface bound one and the percent
of positive cells ranged from 10 to 100. PCI37A,
PCI37B and Hep-2 cell lines demonstrated relatively
highest expression. The cause of it is unknown, but at
least two from the above  mentioned cancers have been
metastatic (see Table 1). It might suggest that high
expression of TLRs may promote tumor growth. It is in
line with reports of other investigators which have
shown enhancing effect of TLR4 and TLR 9 on tumor
growth respectively [20, 21].  Some of us have demon-
strated recently tumor growth promoting effect of TLR4
in squamous cell head and neck carcinomas [22]. It is of
interest   that in molecular studies of the current work
mRNA of TLRs from 1 to 10 could be detected by rt
PCR reaction in all cell lines tested. It indicates that can-
cer cells  possess molecular potential ready to produce
TLR protein molecules if needed for tumor advantage. It
is plausible, if one remembers how tumor microenviron-
ment may fluctuate during various stages of tumor devel-
opment. Head and neck cancer cells encounter not only
tumor-infiltrating lymphocytes, macrophages, proliferat-
ing endothelial cells and/or fibroblasts but also heavy
burden of bacterial flora being constant phenomenon in
advanced cancers. It certainly requires differentiated
response to such rich panel of stimuli.
Co-culture of cells with ligands was aimed to show
the effect of the latter on TLR expression. Unfortu-
nately, not all TLRs  ligands were available. Those
which were, demonstrated rather unexpected pattern
after 24 hrs co-culture with tumor cells. Cytoplasmic
TLR expression of cells was usually higher than that
with ligand.  TLR surface expression with ligand
became however higher than  without ligand,
although this increase was not very impressive. It may
suggest that cancer cell-ligand interaction may not
necessarily lead to cell stimulation, as it is in the case
of normal cells. Instead, it may result in transfer of
TLR  to cell interior, presumably to tumor advantage,
as it has been shown recently for LPS -TLR4 interac-
tion [22]. This is only the presumption that requires
further study. An example of Drosophila indicates
however, that TLRs may carry out other functions
apart from the response to infection. Rydberg et al.
[23] have demonstrated that head and neck squamous
carcinoma cell lines, following culture with TLR ago-
nists undergo inflammation or even cell death. We did
not observe such phenomena,  presumably due to rel-
atively low dosage of ligand used as recommended by
manufacturer. On the other hand, there are data from
the literature that TLRs may prevent apoptosis, pro-
mote repair following lung injury, protect gut epithe-
lium from injury etc [24]. There are also reports that
some TLR agonists, such as imiquimod used in the
Fig. 4. (A) Surface expression of
TLR7 on HeP-2 cells cultured with-
out ligand. (B) As above but in the
presence of ligand. Visible an
increase of surface TLR7 expression
following culture with ligand. (C)
Cytoplasmic expression of TLR7 on
HeP-2 cells cultured without ligand.
(D) As above but in the presence of
ligand. Visible fall of TLR7 expres-
sion, presumably due to its expulsion
on cell surface.
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current study, may have anti-tumor effect, both
applied topically in skin cancers and as systemic one
in melanoma [25].
In conclusion, the above presented data provide
some evidence of almost universal expression of func-
tional Toll-like receptors on laryngeal carcinoma cell
lines. Their impact on tumor growth and progression
remains to be elucidated. 
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